These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 1271279)

  • 21. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of the antidepressant binodaline on biogenic amine uptake and brain levels in the rat.
    Benfield DP; Luscombe DK
    Arzneimittelforschung; 1983; 33(6):847-50. PubMed ID: 6684438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of the antidepressant activity of the enantiomers of bupropion.
    Musso DL; Mehta NB; Soroko FE; Ferris RM; Hollingsworth EB; Kenney BT
    Chirality; 1993; 5(7):495-500. PubMed ID: 8240925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine.
    Horn AS; Snyder SH
    J Pharmacol Exp Ther; 1972 Mar; 180(3):523-30. PubMed ID: 5012779
    [No Abstract]   [Full Text] [Related]  

  • 25. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The action of 1-aminoadamantane. Comparative studies with isolated nerve endings and thrombocytes on the release of serotonin and dopamine].
    Haacke U; Sturm G; Süwer V; Wesemann W; Wildenhahn G
    Arzneimittelforschung; 1977 Jul; 27(7):1481-3. PubMed ID: 578478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

  • 28. Stereoisomers of viminol: catalepsy and brain monoamine turnover rate.
    Costa E; Cheney D; Revuelta A
    Adv Biochem Psychopharmacol; 1973; 8(0):483-94. PubMed ID: 4800183
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of heavy metals on monoamine uptake and release in brain synaptosomes and blood platelets.
    Komulainen H; Tuomisto J
    Neurobehav Toxicol Teratol; 1982; 4(6):647-9. PubMed ID: 7170022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake.
    Richelson E; Pfenning M
    Eur J Pharmacol; 1984 Sep; 104(3-4):277-86. PubMed ID: 6499924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation of presynaptic components (uptake--release) in antidepressants].
    Dolzhenko AT
    Farmakol Toksikol; 1984; 47(5):22-5. PubMed ID: 6094236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of phenylethanolamine N-methyltransferase inhibitors on uptake and release of norepinephrine and dopamine from rat brain.
    Liang NY; Hower JA; Borchardt RT
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):467-70. PubMed ID: 4059661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of brain noradrenaline, dopamine and 5-hydroxytryptamine levels during vanadium poisoning.
    Witkowska D; Brzeziński J
    Pol J Pharmacol Pharm; 1979; 31(4):393-8. PubMed ID: 523342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue.
    Azzaro AJ; Ziance RJ; Rutledge CO
    J Pharmacol Exp Ther; 1974 Apr; 189(1):110-8. PubMed ID: 4823286
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.
    Raiteri M; Del Carmine R; Bertollini A; Levi G
    Eur J Pharmacol; 1977 Jan; 41(2):133-43. PubMed ID: 832672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the brain biogenic monoamines of rats, induced by piracetam and aniracetam.
    Petkov VD; Grahovska T; Petkov VV; Konstantinova E; Stancheva S
    Acta Physiol Pharmacol Bulg; 1984; 10(4):6-15. PubMed ID: 6535371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
    Masserano JM; Venable D; Wyatt RJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):133-41. PubMed ID: 8035309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Change in the biogenic amine level in the rat brain in ethanol poisoning].
    Blagiva OE; Kalmykov VL
    Biull Eksp Biol Med; 1980 Feb; 89(2):182-4. PubMed ID: 7189422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potassium-induced release of [3H]catecholamine from brain: effects of pre-exposure to catecholamine uptake inhibitors.
    Dembiec D; Cohen G
    J Pharmacol Exp Ther; 1981 Jun; 217(3):727-32. PubMed ID: 7230001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional changes in monoamine content and uptake of the rat brain during postnatal development.
    Nomura Y; Naitoh F; Segawa T
    Brain Res; 1976 Jan; 101(2):305-15. PubMed ID: 1244975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.